Alnylam Pharmaceuticals
ALNY
#755
Rank
$33.21 B
Marketcap
$248.26
Share price
0.71%
Change (1 day)
-45.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company